SEC Form 4 · accession 0001140361-18-044950
Aquestive Therapeutics, Inc. · AQST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alexander Mark Schobel
Officer — Chief Innovation/Tech Officer
Period of report
Dec 10, 2018
Accepted (ET)
Dec 11, 2018 · 5:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001398733
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 10, 2018 | P | 1,000 | $7.78 | A | 1,019,624 | D |
Table II — derivative securities
No Table II lines on this filing.